CD8A and systemic lupus erythematosus: A previous study has shown that the ligation of SLAMF7 in SLE promotes the degranulation of CD8+ T cells in response to viral antigens, therefore empowering the antiviral response that is compromised in patients with SLE (16), highlighting the potential therapeutic benefit of targeting SLAMF7.